140 related articles for article (PubMed ID: 37108061)
21. Increased expression of RBMS3 predicts a favorable prognosis in human gallbladder carcinoma.
Wu Y; Meng D; You Y; Sun R; Yan Q; Bao J; Sun Y; Yun D; Li Y; Sun D
Oncol Rep; 2020 Jul; 44(1):55-68. PubMed ID: 32627033
[TBL] [Abstract][Full Text] [Related]
22. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical evidence of the prognostic value of hedgehog pathway components in primary gallbladder carcinoma.
Li J; Wu T; Lu J; Cao Y; Song N; Yang T; Dong R; Yang Y; Zang L; Du X; Wang S
Surg Today; 2012 Aug; 42(8):770-5. PubMed ID: 22407314
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological significance of SLP-2 overexpression in human gallbladder cancer.
Wang WX; Lin QF; Shen D; Liu SP; Mao WD; Ma G; Qi WD
Tumour Biol; 2014 Jan; 35(1):419-23. PubMed ID: 23918306
[TBL] [Abstract][Full Text] [Related]
25. Clinical implication of TMPRSS4 expression in human gallbladder cancer.
Wu XY; Zhang L; Zhang KM; Zhang MH; Ruan TY; Liu CY; Xu JY
Tumour Biol; 2014 Jun; 35(6):5481-6. PubMed ID: 24532432
[TBL] [Abstract][Full Text] [Related]
26. Significance of methylation status of MASPIN gene and its protein expression in prognosis of gallbladder cancer.
Baghel K; Kazmi HR; Chandra A; Raj S; Srivastava RN
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e120-e125. PubMed ID: 30740890
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer.
Li M; Zhang S; Wang Z; Zhang B; Wu X; Weng H; Ding Q; Tan Z; Zhang N; Mu J; Yang J; Shu Y; Bao R; Ding Q; Wu W; Cao Y; Liu Y
Tumour Biol; 2013 Dec; 34(6):3995-4000. PubMed ID: 23857283
[TBL] [Abstract][Full Text] [Related]
28. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
[TBL] [Abstract][Full Text] [Related]
29. Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection: a retrospective and in vitro study.
Shu YJ; Weng H; Bao RF; Wu XS; Ding Q; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Li ML; Mu JS; Wu WG; Liu YB
BMC Cancer; 2014 Aug; 14():566. PubMed ID: 25096189
[TBL] [Abstract][Full Text] [Related]
30. HER2 status based on breast cancer guidelines as a useful prognostic marker of T2 gallbladder cancer.
Kwon CH; Seo HI; Kim DU; Han SY; Kim S; Lee SJ; Jeon DY
Eur J Surg Oncol; 2023 Feb; 49(2):392-398. PubMed ID: 36369228
[TBL] [Abstract][Full Text] [Related]
31. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
Luo F; Zhao Y; Liu J
Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
[TBL] [Abstract][Full Text] [Related]
32. Low expression of equilibrative nucleoside transporter 1 is associated with poor prognosis in chemotherapy-naïve pT2 gallbladder adenocarcinoma patients.
Espinoza JA; García P; Bizama C; Leal JL; Riquelme I; Weber H; Macanas P; Aguayo G; Viñuela E; Roa JC; Nervi B
Histopathology; 2016 Apr; 68(5):722-8. PubMed ID: 26266900
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.
Varga M; Obrist P; Schneeberger S; Mühlmann G; Felgel-Farnholz C; Fong D; Zitt M; Brunhuber T; Schäfer G; Gastl G; Spizzo G
Clin Cancer Res; 2004 May; 10(9):3131-6. PubMed ID: 15131054
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and Clinicopathological Significance of X-Box-Binding Protein 1 and N-Acetyltransferase 1 in Gallbladder Cancer.
Liu R; Wu Z; Zhang Y; Miao X; Zou Q; Yuan Y; Li D; Yang Z
Front Oncol; 2020; 10():1124. PubMed ID: 32793479
[No Abstract] [Full Text] [Related]
35. Prognostic significance of immune cells in the tumor microenvironment and peripheral blood of gallbladder carcinoma patients.
Zhang Y; Ma C; Wang M; Hou H; Cui L; Jiang C; Sun J; Qu X
Clin Transl Oncol; 2017 Apr; 19(4):477-488. PubMed ID: 27718154
[TBL] [Abstract][Full Text] [Related]
36. NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer.
Xiong L; Wen Y; Miao X; Yang Z
Cell Tissue Res; 2014 Feb; 355(2):365-74. PubMed ID: 24310606
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical expression and prognostic value of CD97 and its ligand CD55 in primary gallbladder carcinoma.
Wu J; Lei L; Wang S; Gu D; Zhang J
J Biomed Biotechnol; 2012; 2012():587672. PubMed ID: 22547928
[TBL] [Abstract][Full Text] [Related]
38. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway.
Shen H; He M; Lin R; Zhan M; Xu S; Huang X; Xu C; Chen W; Yao Y; Mohan M; Wang J
J Exp Clin Cancer Res; 2019 Jun; 38(1):247. PubMed ID: 31182136
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological significance of HuR expression in gallbladder carcinoma: with special emphasis on the implications of its nuclear and cytoplasmic expression.
Sun DP; Lin CY; Tian YF; Chen LT; Lin LC; Lee SW; Hsing CH; Lee HH; Shiue YL; Huang HY; Li CF; Liang PI
Tumour Biol; 2013 Oct; 34(5):3059-69. PubMed ID: 23722602
[TBL] [Abstract][Full Text] [Related]
40. Connective tissue growth factor immunohistochemical expression is associated with gallbladder cancer progression.
Garcia P; Leal P; Alvarez H; Brebi P; Ili C; Tapia O; Roa JC
Arch Pathol Lab Med; 2013 Feb; 137(2):245-50. PubMed ID: 23368866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
